The Pioppi Diet | 1
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
SP11 and SP12 POST PUBLICATION CORRESPONDENCE BETWEEN FIONA GODLEE the BMJ and MALHOTRA
SP11 and SP12 POST PUBLICATION CORRESPONDENCE BETWEEN FIONA GODLEE THE BMJ AND MALHOTRA On 21 Mar 2014, at 18:13, "Fiona Godlee" <[email protected]> wrote: Dear Aseem. Good to talk just now. Lots to discuss and well done with all you are doing. Thank you for saying you will answer the four remaining rapid responses that raise criticisms of your piece on saturated fats. As I said on the phone we will need you to do this before we take on further pieces. We now post an editor's note in rapid responses where what we consider to be substantive criticisms remain unaddressed, saying we have asked the authors to respond and they have not done so. Sorry of this seems brutal but we show no favouritism. We have done it to and colleagues just as an example. Sharon can send you links to the RRs in question if that will help. Please could you send your response by the end of next week (Friday 28 March). Thanks and best wishes. Fi On 21 Mar 2014, at 18:19, aseem <[email protected]> wrote: Thanks FI, I will sort ASAP Best Aseem BMJ Rapid responses Inbox x aseem <[email protected]> 28 Mar to me Dear FI, Just to let you know that as promised I have just submitted the response to Sharon. A copy is attached for your interest. Very Best Malhotra responses The Zhang paper reported that almost 1 in 5 (17.4%) or 18,778 out of 107,835 patients treated with a statin in a routine care setting had a “statin-related adverse event documented.” The most commonly documented side effect was myalgia or myopathy with others including musculoskeletal and connective tissue disorders , general disorders, hepatobiliary disorders, gastrointestinal disorders, memory problems and drug intolerance.1,2 In fact the overall initial rate of discontinuation for all causes that occurred at least once for the 107,835 patients analysed in the study was far higher at 53.1% (57,292 patients) for reasons that also included the drug being “no longer necessary” or the patients not wanting to take it. -
Saturated Fat Does Not Clog the Arteries: Coronary Heart Disease Is A
Downloaded from http://bjsm.bmj.com/ on November 13, 2017 - Published by group.bmj.com Editorial 7500 high-risk patients. Furthermore, the Saturated fat does not clog the arteries: Lyon Heart study showed that adopting a Mediterranean diet in secondary coronary heart disease is a chronic prevention improved hard outcomes for both recurrent myocardial infarc- inflammatory condition, the risk of tion (NNT=18) and all-cause mortality (NNT=30), despite there being no signif- which can be effectively reduced from icant difference in plasma low-density lipoprotein (LDL) cholesterol between the two groups. It is the alpha linoleic healthy lifestyle interventions acid, polyphenols and omega-3 fatty acids 1 2,3 4,5 present in nuts, extra virgin olive oil, vege- Aseem Malhotra, Rita F Redberg, Pascal Meier tables and oily fish that rapidly attenuate inflammation and coronary thrombosis.6 Coronary artery disease pathogenesis and testing.4 When plaques rupture (analogous Both control diets in these studies were treatment urgently requires a paradigm to a pimple bursting), coronary throm- relatively healthy, which make it highly shift. Despite popular belief among bosis and myocardial infarction can occur likely that even larger benefits would doctors and the public, the conceptual within minutes. The limitation of the be observed if the Mediterranean diets model of dietary saturated fat clogging a current plumbing approach (‘unclogging discussed above were compared with a pipe is just plain wrong. A landmark a pipe’) to the management of coronary typical western diet. systematic review and meta-analysis of disease is revealed by a series of randomised observational studies showed no associa- controlled trials (RCTs) which prove that LDL CHOLESTEROL RISK HAS BEEN tion between saturated fat consumption stenting significantly obstructive stable EXAGGERATED and (1) all-cause mortality, (2) coronary lesions fail to prevent myocardial infarc- Decades of emphasis on the primacy of 5 heart disease (CHD), (3) CHD mortality, tion or to reduce mortality. -
SP9 – Pre-Publication History for Malhotra Et Al
SP9 – Pre-publication history for Malhotra et al From: aseem malhotra Date: Friday, September 27, 2013 Subject: Re: Request to peer review a column for the BMJ To: Rebecca Coombes <[email protected]> Hi Rebecca, I am in the final stages of a potentially game changing and much needed piece busting the myth of saturated fat and heart disease. It is well referenced including a strong evidence base for why all calories are not the same and I also briefly question statins in primary prevention and provide an explanation why the evidence is weak for benefit here. This is something I have conceived and looked into for over a year now. I can and was planning to do it for the Observations column but it's close to 1600 words and thought it may be more suitable as a feature? But I don't know what your requirements/usual process is for feature pieces? I have a heads up that the WHO is going to announce a revision on dietary guidelines on sugar at the end of October and the Scientific advisory committee on nutrition is currently reviewing dietary guidelines on carbs. But I am not confident that they will be totally impartial as one of their lead scientists has recently been exposed as being on the pay roll of Coca Cola! I therefore ideally want to publish this in the next few weeks but if it is not something you see as viable for features then I would shorten it down and do it for Observations but just thought it was worth asking you first! Best AseemAseem From: Rebecca Coombes <[email protected]> Date: 27 September 2013 17:37 Subject: Fwd: Request to peer review a column for the BMJ To: Trevor Jackson <[email protected]> Trevor, I haven't replied to this yet but it strikes me as more of an analysis than a feature. -
How a Structured Exercise Programme Involving Cardio and Resistance Exercise Affects Type 2 Diabetes Mellitus Volunteers
How a structured exercise programme involving cardio and resistance exercise affects type 2 diabetes mellitus volunteers Ashley Hill BA(Hons) July 2019 First supervisor: Professor M Joan Taylor Second supervisor: Dr Tarsem Sahota This thesis is submitted for the fulfilment of the requirements of the degree of Master of Philosophy Leicester School of Pharmacy Department of Health and Life Science Abstract Background T2DM is a metabolic disorder that is rapidly increasing in prevalence, it has become a 21st century epidemic and addressing this is one of the greatest global health challenges of our time. In the UK £10.3 billion or 10% of the NHS budget was spent on diabetes mellitus. It is essential that a prevention approach to T2DM is utilised within the NHS. Aims The aims of this study are to compare physiological, metabolic parameters and inflammatory markers from type 2 diabetes mellitus (T2DM) and non-diabetic (ND) volunteers over a 6-week exercise period. Methods This was a very interesting study where T2DM and ND volunteers completed one of three structured exercise programmes involving either a combination of cardio and resistance exercise, cardio exercise or resistance exercise twice a week for 6- weeks. Various parameters were recorded at baseline to compare with results after 1 exercise session and again after 12 exercise sessions. Key findings Oral glucose tolerance test area under the curve results showed noticeable reductions from 1612.40 to 1354.10 mmol/L*min. Weight reduced by 2.58 kg in the T2 combination group after intervention which showed a statistically significant reduction from before to after intervention with a p-value of 0.049. -
Aseem Malhotra: Lessons in Public Health Advocacy
Aseem Malhotra: Lessons in Public Health Advocacy Transcribed from a presentation at a CrossFit Health event on Dec. 15, 2019: Thank you, Gary, for those very kind words. I'm really honored, actually, to be here. Special thank you to Greg and the CrossFit team for inviting me out here to speak to you guys. The Wikipedia page is interesting, and I didn't expect Gary to actually read it out today, although he did — I thought when he asked for permission he was just kidding. But hopefully you'll get a gist of what the — whether the accuracy of that Wikipedia page on my, kind of, bio from my talk today, because I do cover a lot of these areas and issues. First and foremost, as Gary said, I'm a cardiologist. I qualified in 2001 from Edinburgh. For me, this journey is really just about doing the right thing by my patient. That's it. It's my duty, my responsibility, and everything I do, I always think about that patient in front of me and the wider determinants of health. And I've done many different things as well as being a cardiologist and being an activist. I try and influence government policy as well as public health advocacy. I do a lot of private advocacy as well. So I'll go through some of those, that journey with you in the next hour or so, and hopefully we'll have some time for questions afterwards. But I want to start with something called the Seven Nolan Principles. -
Saturated Fat Does Not Clog the Arteries: Coronary Heart Disease Is
Downloaded from http://bjsm.bmj.com/ on March 12, 2018 - Published by group.bmj.com Editorial 7500 high-risk patients. Furthermore, the Saturated fat does not clog the arteries: Lyon Heart study showed that adopting a Mediterranean diet in secondary coronary heart disease is a chronic prevention improved hard outcomes for both recurrent myocardial infarc- inflammatory condition, the risk of tion (NNT=18) and all-cause mortality (NNT=30), despite there being no signif- which can be effectively reduced from icant difference in plasma low-density lipoprotein (LDL) cholesterol between the two groups. It is the alpha linoleic healthy lifestyle interventions acid, polyphenols and omega-3 fatty acids 1 2,3 4,5 present in nuts, extra virgin olive oil, vege- Aseem Malhotra, Rita F Redberg, Pascal Meier tables and oily fish that rapidly attenuate inflammation and coronary thrombosis.6 Coronary artery disease pathogenesis and testing.4 When plaques rupture (analogous Both control diets in these studies were treatment urgently requires a paradigm to a pimple bursting), coronary throm- relatively healthy, which make it highly shift. Despite popular belief among bosis and myocardial infarction can occur likely that even larger benefits would doctors and the public, the conceptual within minutes. The limitation of the be observed if the Mediterranean diets model of dietary saturated fat clogging a current plumbing approach (‘unclogging discussed above were compared with a pipe is just plain wrong. A landmark a pipe’) to the management of coronary typical western diet. systematic review and meta-analysis of disease is revealed by a series of randomised observational studies showed no associa- controlled trials (RCTs) which prove that LDL CHOLESTEROL RISK HAS BEEN tion between saturated fat consumption stenting significantly obstructive stable EXAGGERATED and (1) all-cause mortality, (2) coronary lesions fail to prevent myocardial infarc- Decades of emphasis on the primacy of 5 heart disease (CHD), (3) CHD mortality, tion or to reduce mortality. -
The Synapse 15-4
nutritional perspectiVe cholesterol & statins the controVersy continues albErt cilia-viNcENti recent widely publicised Lancet review of statin efficacy and the adverse effects (such as myopathy) can be reversed with no safety data generated more controversy than it resolved.1 Led residual ill-effects by stopping the statin, the effects of a heart aby Professor Rory Collins of Oxford University, the review attack or stroke are often irreversible. claimed that the benefits of statins have been underestimated Dr Harlan Krumholz (Yale University), commenting on the and the risks exaggerated. Claims of statin intolerance in up to review in the BMJ,3 said that while the findings strongly support 20% of patients, the review argues, are not supported by large- the benefits of statins in comparison to modest risks, there is scale evidence from randomised trials. In fact, Collins et al. little consideration of the limitations of the trial evidence, most claim that statin therapy is no less well tolerated than placebo. notably a lack of robust data on elderly patients, individual trials Collins further claimed that the controversy about statin whose design prevented detection of many relevant harms, and intolerance and myopathy rates emerged only in the past 2 or inconsistent methods for adverse event data collection. 3 years as manufacturers began marketing newer and “very A vocal critic of the review, and an author of one of the expensive” cholesterol-lowering agents, such as, proprotein 2013 BMJ papers,4 Dr Aseem Malhotra (Lister Hospital, convertase subtilisin/kexin type 9 (PCSK9) inhibitors for Stevenage, UK) claims that the Clinical Trials Service Unit at patients classified as statin intolerant. -
Factors Influencing the Choice of Fats in a High Fat Diet; a Guide for the Perplexed
“All That Fat” - Factors influencing the choice of fats in a high fat diet; A Guide for the Perplexed George Henderson, research assistant, Human Potential Centre, Auckland University of Technology. July 2014 The question I hear most often when introducing audiences to LCHF or Paleo concepts is some variant of “aren’t you worried about all that fat?” The idea that fat is fattening is the easy one to address, plenty of people have lost weight publically on high-fat diets, the fattening carbohydrate was never really forgotten, and contrary ideas have a degree of attractiveness. The question of cholesterol and heart disease, or other diseases presumably involving lifelong processes that are mysterious to the average person (and far from clear to scientists), is a harder one to answer. My purpose here is not to answer it conclusively, but to place it in context. There are four basic positions when it comes to dietary saturated fat, cholesterol, and animal fat as dietary risk factors (note that I include dietary cholesterol). The classic view, developed by Ancel Keys and promoted widely, is that these dietary risk factors (DRF) promote the development of coronary heart disease, and that replacing them with other foods – mainly carbohydrate and polyunsaturated vegetable fat, but also some additional fibre and long-chain omega 3s (it is arguable that neither of these latter two actually supplies enough energy to be taken seriously as a “substitution”, being rather in the nature of “supplements”) – reduces this risk. A secondary assumption often tacked onto the classic view in popular science writing, and which had some official backing until recently, is that the DRFs play a role in other diseases, such as cancers. -
Saturated Fat Is Not the Major Issue Let’S Bust the Myth of Its Role in Heart Disease
BMJ 2013;347:f6340 doi: 10.1136/bmj.f6340 (Published 22 October 2013) Page 1 of 2 Observations OBSERVATIONS FROM THE HEART Saturated fat is not the major issue Let’s bust the myth of its role in heart disease Aseem Malhotra interventional cardiology specialist registrar, Croydon University Hospital, London Indeed, recent prospective cohort studies have not supported any significant association between saturated fat intake and cardiovascular risk.5 Instead, saturated fat has been found to be protective. The source of the saturated fat may be important. Dairy foods are exemplary providers of vitamins A and D. As well as a link between vitamin D deficiency and a significantly increased risk of cardiovascular mortality, calcium and phosphorus found commonly in dairy foods may have antihypertensive effects that may contribute to inverse associations with cardiovascular risk.6-8 One study showed that higher concentrations of plasma trans-palmitoleic acid, a fatty acid mainly found in dairy foods, was associated with higher concentrations of high density lipoprotein, lower concentrations Scientists universally accept that trans fats—found in many fast of triglycerides and C reactive protein, reduced insulin foods, bakery products, and margarines—increase the risk of 9 1 resistance, and a lower incidence of diabetes in adults. Red cardiovascular disease through inflammatory processes. But meat is another major source of saturated fat. Consumption of “saturated fat” is another story. The mantra that saturated fat processed meats, but not red meat, has been associated with must be removed to reduce the risk of cardiovascular disease coronary heart disease and diabetes mellitus, which may be has dominated dietary advice and guidelines for almost four 10 explained by nitrates and sodium as preservatives. -
Dr Aseem Malhotra, Honorary Consultant Cardiologist
Dr Aseem Malhotra, Honorary Consultant Cardiologist, Lister Hospital Stevenage Academy of Medical Royal Colleges Choosing Wisely Steering Group King’s Fund – Member of Board of Trustees “ Half of what you learn in medical school will be shown to be either dead wrong or out of date within 5 years of your graduation; the trouble is nobody can tell you which half. The most important thing to learn is how to learn on your own” David Sackett Ideal Risk Factor Framingham Heart Study Castelli W. Atherosclerosis 1996;124 Suppl:S1- Ann Intern Med 1979; 90:85-91 S9 What do Leading-Edge Experts Say? ‘Cholesterol and Disease’ Experts are called ‘Lipidologists’ One of the USA’s foremost is Thomas Dayspring, MD, FACP, FNLA, NCMP . Clinical Assistant Professor of Medicine, Director of Cardiovascular Education “The [Total/HDL] RATIO was found to be a better predictor of CHD than TC, LDL, HDL and triglyceride -- not only in the Framingham Study, 2) LDLcbut alsois in a the near Physician's-worthless Health predictor Study and manyfor cardiovascular other studies.” issues* - William P. Castelli (Framingham Director) Atherosclerosis 124 Suppl. (1996) Lipids, risk factors and Ischaemic heart disease S1-$9 Are we giving the wrong dietary advice on saturated fat? 1970 American Scientist Ancel Keys, 7 countries study- saturated fat – increased cholesterol- main dietary cause of heart disease. Change in dietary advice in 1977/1984 – eat less fat and more carbs! ( <30% fat <10% sat fat) Food industry exploitation of “low fat” mantra has resulted in diets high in refined carbohydrates (sugar) Prevalence of obesity and type 2 diabetes in western population has rocketed since. -
Hit Or Miss: the New Cholesterol Targets
EBM analysis: Primary care Hit or miss: the new cholesterol targets Robert DuBroff ,1 Aseem Malhotra,2 Michel de Lorgeril3 10.1136/bmjebm-2020-111413 Abstract Individuals with LDL- C ≥190 mg/dL Drug treatment to reduce cholesterol to new target Individuals aged 40–75 without ASCVD or diabetes with LDL-C between 70 and 1Internal Medicine/ levels is now recommended in four moderate- 189 mg/dL and 10- year ASCVD risk ≥20% Cardiology, University of New to high- risk patient populations: patients who Mexico, Albuquerque, New have already sustained a cardiovascular event, For individuals at moderate risk, the guide- Mexico, USA adult diabetic patients, individuals with low lines recommend reducing LDL- C by 30% or more. 2Visiting Professor of density lipoprotein cholesterol levels ≥190 mg/ For those at high risk, LDL- C should be reduced Evidence- Based Medicine, dL and individuals with an estimated 10- year by 50% or more. The new guidelines recommend Bahiana School of Medicine, cardiovascular risk ≥7.5%. Achieving these three classes of drugs for cholesterol reduction: Salvador, Brazil β-Hydroxy β-methylglutaryl- CoA (HMG- CoA) 3 cholesterol target levels did not confer any Equipe Coeur & Nutrition, additional benefit in a systematic review of 35 reductase inhibitors (statins), cholesterol absorp- University of Grenoble, randomised controlled trials. Recommending tion inhibitors (ezetimibe) and proprotein conver- Grenoble, France cholesterol lowering treatment based on estimated tase subtilisin/kexin type 9 inhibitors (PCSK9). cardiovascular risk fails to identify many high- risk Correspondence to: patients and may lead to unnecessary treatment Randomised controlled trials Dr Robert DuBroff, Internal of low- risk individuals. -
The Slippery Science of Fat Separating Fat from Fiction
The Slippery Science of Fat Separating Fat From Fiction Mark Hyman, MD Director, Cleveland Clinic Center for Functional Medicine Pritzker Foundation Chair in Functional Medicine, Cleveland Clinic Lerner College of Medicine Chairman, Institute for Functional Medicine March 12, 2015 The truth is rarely pure and never simple. Oscar Wilde Overview of Today! • Our Big Fat Mess • The Perfect Storm • Food as Medicine: The Matrix and Fat • Biology of Obesity • Slippery Science of Fat • Fat and Heart Disease • Saturated Fat and Heart Disease • Cholesterol and Statins • Understanding PUFA’s – Omega 6 and Omega 3 fat Overview of Today • Meat? To Eat or Not to Eat • Areas of Agreement – Olive oil, Nuts, Trans Fats • Controversies: Eggs, Meat, Coconut Oil • What Should I Eat? The Pegan Diet 75% of Americans 40% of children = Age-adjusted Prevalence of Obesity and Diagnosed Diabetes Among US Adults Obesity (BMI ≥30 kg/m2) 1994 2000 2013 No Data <14.0% 14.0%–17.9% 18.0%–21.9% 22.0%–25.9% > 26.0% Diabetes 1994 2000 2013 No Data <4.5% 4.5%–5.9% 6.0%–7.4% 7.5%–8.9% >9.0% CDC’s Division of Diabetes Translation. National Diabetes Surveillance System available at http:// www.cdc.gov/diabetes/statistics Origins of Diet-Heart & Dietary Fat – Obesity Hypothesis • The Perfect Storm • Scientists: Ancel Keys – 7 Countries Study – Professional Associations: AHA, ADA, AND – USDA Dietary Guidelines • McGovern Report:1977 Diet Guidelines • 1992 Food Pyramid • My Plate • 2015 Dietary Guidelines = 180 degree turn! – Food Industry • 600,000 food products mostly low fat with added sugar Current View of Obesity: Lack of Willpower • Energy Balance: Fact or Fiction? – Calories In/Calories Out? – Global Energy Balance Network? • Food Industry/Government Policy – Eat More, Exercise Less? • Moderation – No Good or Bad Calories? • Exercise? – Is it a viable weight loss strategy = Walk 4.5 miles = 4 miles a day for one week Sugar, Fat and CVD • Large meta-analysis of 72 studies on fat show no link with CVD except trans fats – Ann Intern Med.